Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormonal therapies are safe and effective for treating adult women's acne.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Menopause can cause skin issues, and seeing a dermatologist helps.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Androgens can both increase body hair and cause scalp hair loss.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Minoxidil and finasteride combined can effectively treat hair loss.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.